---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000367"
form_type: "8-K"
ticker: null
cik: "0001476963"
company_name: "Scorpius Holdings, Inc."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T22:07:53.147565+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Scorpius extends rights plan to March 2025; closes 10M-share public offering for $1.5M

## Summary
- Amendment No. 7 extends stockholder rights plan expiration to March 11, 2025, or earlier redemption/exchange.
- Closed public offering of 10,000,000 common shares at $0.15 per share for $1.5M gross proceeds.
- Net proceeds will be used for working capital and general corporate purposes.
- ThinkEquity acted as sole book-running manager for the offering.

## SEC filing metadata
- accession: 0001079973-24-000367
- form_type: 8-K
- cik: 0001476963
- company_name: Scorpius Holdings, Inc.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1476963/000107997324000367/0001079973-24-000367-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1476963/000107997324000367/scpx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000367
- JSON: https://secwatch.observer/filing/0001079973-24-000367.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000367.txt

## Key facts
- Material Agreements
  Scorpius Holdings, Inc. amended Amendment No. 7 with Continental Stock Transfer & Trust Company (effective 2024-03-11).
  - Action: amendment
  - Counterparty: Continental Stock Transfer & Trust Company
  - Effective: 2024-03-11
  source text: On March 11, 2024, Scorpius Holdings, Inc. (formerly known as NightHawk Biosciences, Inc.) (the “Company”) entered into Amendment No. 7 (“Amendment No. 7”) dated March 11, 2024 to the Rights Agreement dated March 11, 2018 (the “Original Rights Agreement”), as amended by Amendment No. 1 thereto (“Amendment No. 1”) dated March 8, 2019, Amendment No. 2 thereto (“Amendment No. 2”) dated March 10, 2020, Amendment No. 3 thereto (“Amendment No. 3”) dated March 8, 2021, Amendment No. 4 thereto (“Amendment No. 4”) dated March 11, 2022, Amendment No. 5 thereto (“Amendment No. 5”) dated March 11, 2023, and Amendment No. 6 thereto (“Amendment No. 6”) dated December 11, 2023 (collectively, the “Rights Agreement”) by and between the Company and Continental Stock Transfer & Trust Company, as rights agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1476963/000107997324000367/0001079973-24-000367-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.